Laboratory and Imaging Test Results in Fibromyalgia
In fibromyalgia, laboratory and imaging tests are typically normal, with no specific diagnostic findings that confirm the condition. 1 This is a key characteristic that distinguishes fibromyalgia from other rheumatologic conditions.
Normal Laboratory Findings
- Complete blood count (CBC): Normal
- Erythrocyte sedimentation rate (ESR): Normal
- C-reactive protein (CRP): Normal
- Rheumatoid factor (RF): Negative
- Anti-nuclear antibodies (ANA): Negative
- Anti-citrullinated protein antibody (anti-CCP): Negative
- Thyroid function tests: Normal
- Creatine kinase (CK): Normal (important to differentiate from inflammatory myositis)
- Comprehensive metabolic panel: Normal
Normal Imaging Results
- X-rays: No evidence of joint damage, erosions, or abnormalities
- MRI: No evidence of inflammation or structural abnormalities
- Ultrasound: No evidence of synovitis or joint effusion
Diagnostic Approach
Fibromyalgia is diagnosed clinically using the American College of Rheumatology (ACR) criteria, which focus on:
- Widespread pain index (WPI): Assessment of pain distribution throughout the body
- Symptom severity scale (SS): Evaluation of fatigue, cognitive symptoms, and sleep disturbances
- Tender point examination: Historically, pain upon digital pressure in at least 11 of 18 specific tender points was required for diagnosis 1
Key Diagnostic Considerations
- Laboratory and imaging tests in fibromyalgia are primarily used to rule out other conditions that may present with similar symptoms
- The absence of abnormal findings in these tests, combined with characteristic symptoms, supports a fibromyalgia diagnosis
- Patients often undergo extensive testing before receiving a correct diagnosis of fibromyalgia 2
Common Pitfalls in Diagnosis
- Over-reliance on laboratory tests: Expecting to find abnormal test results to confirm fibromyalgia
- Failure to recognize normal test results as supportive: Normal results actually support the diagnosis when clinical symptoms are consistent with fibromyalgia
- Unnecessary testing: Ordering extensive panels or specialized tests when basic screening is sufficient
- Missing comorbid conditions: Failing to test for conditions that commonly coexist with fibromyalgia
Differential Diagnosis Considerations
When evaluating test results, consider these conditions that may present similarly but show abnormal laboratory findings:
- Inflammatory arthritis: Elevated ESR/CRP, positive RF or anti-CCP
- Polymyalgia rheumatica: Markedly elevated inflammatory markers (ESR/CRP)
- Myositis: Elevated muscle enzymes (CK)
- Hypothyroidism: Abnormal thyroid function tests
- Multiple sclerosis: Abnormal MRI findings
- Lyme disease: Positive serologic testing 3
Clinical Application
When evaluating a patient with suspected fibromyalgia:
- Perform targeted laboratory testing to rule out other conditions
- Interpret normal results as supportive of fibromyalgia diagnosis when clinical presentation is consistent
- Avoid repeated or unnecessary testing once other conditions have been ruled out
- Focus on symptom assessment using validated tools rather than continuing to search for laboratory abnormalities
Remember that fibromyalgia is a clinical diagnosis, and the absence of abnormal laboratory or imaging findings in a patient with characteristic symptoms is actually diagnostic of the condition rather than a diagnostic failure.